Blaming the manufacturers for irresponsible marketing is a red herring, writes Peter Clark of the World Vapers' Alliance.Read More
Tags :Zyn
The misleading-marketing claim is preempted by FDA’s authorization, says the multinational. Read More
The investment will help the company meet voracious demand for its nicotine pouch. Read More
The firm will invest $600 million in a Colorado plant to meet ferocious U.S. demand. Read More
The District of Columbia is investigating potential violations of a local flavor ban.Read More
The product were sold without market authorization, according to the agency. Read More
The scarcity comes after PMI reported U.S. volumes of the pouches jumped 80 percent.Read More
The FDA has issued 119 warning letters and filed 41 civil money penalty complaints.Read More
The case could take years to work its way through the courts, according to attorneys.Read More
Manufacturers must show the benefit of pouches and quantify underage usage. Read More